Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TMS for Anxiety and Trauma-related Disorders

NCT: NCT06475040 · COMPLETED

NCT IDNCT06475040
StatusCOMPLETED
Start Date2024-06-19
Completion2025-04-13
SponsorShanghai Mental Health Center (OTHER)
First posted
Last updated

Brief Summary

The present pilot study will apply accelerated intermittent theta burst stimulation (aiTBS) to a novel transcranial magnetic stimulation (TMS) target for anxiety derived via causal network mapping.

Frequently Asked Questions

What is TMS for Anxiety and Trauma-related Disorders?

TMS for Anxiety and Trauma-related Disorders is a clinical trial registered under NCT06475040. Current status: COMPLETED.

What is the status of NCT06475040?

The current status of NCT06475040 (TMS for Anxiety and Trauma-related Disorders) is: COMPLETED.

When did TMS for Anxiety and Trauma-related Disorders start?

TMS for Anxiety and Trauma-related Disorders started on 2024-06-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.